CITY OF HOPE: State of the Art of Cancer Therapeutics: Focus on Relapsed/Refractory Multiple Myeloma

National Live Broadcast Grand Rounds

CITY OF HOPE: State of the Art of Cancer Therapeutics: Focus on Relapsed/Refractory Multiple Myeloma

Activity Information:
Day: Tuesday, April 16, 2019
Time: 12:00 pm-1:00 pm PST
AMA PRA Category 1 Credit™ Issued: 1.0

Moderator/Presenter(s):

Amrita Krishnan, MD
Professor, Department of Hematology and Hematopoietic Cell Transplantation
Director, Judy and Bernard Briskin Center for Multiple Myeloma Research
City of Hope

Objectives:

• Determine optimal therapy/treatment for patients who have multiple myeloma based on the latest clinical data.
• Integrate and personalize new treatment options for multiple myeloma into clinical practice based on the latest clinical trial data, evidence and recommendations

Educational Format:

This activity will be didactic with a Q & A period. This activity will be evaluated by each participant at the conclusion of the lecture.

Target Audience:

This activity has been designed to address the educational needs of community and institution-based medical oncologists, hematologists, surgical oncologists, interventional radiologists, pathologists, PAs, nurse practitioners, oncology nurses, pharmacists, and other healthcare providers involved in the management of patients with cancer.

Provider Statement:

This activity is provided by City of Hope in collaboration with Paradigm Medical Communications, LLC, as an educational partner.

Accreditation Statement:

City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation:

City of Hope designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

PA Continuing Education:

PAs may claim a maximum of 1.0 Category 1 credit for completing this activity. NCCPA accepts AMA PRA Category 1 Credit^TM from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioner Continuing Education:

The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit^TM from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Allied Health Care Professionals:

Registered nurses may report up to 1.0 credit hour toward the continuing education requirement for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit_TM may be noted on the license renewal application in lieu of a BRN provider number. The National Commission on Certification of Physician Assistants states that AMA PRA Category 1 Credit^TM accredited courses are acceptable for continuing medical education requirements for recertification.

To receive a CME certificate of participation for this activity, participants must:

• Create an individual registration profile

• Individually sign in to the Zoom link using your Full Name and email as it appears on your registration

• View the webcast in its entirety

• After the meeting you will also receive an email with instructions to log in, complete, and submit your online posttest and evaluation. You must claim credit within 7 days of the live stream.

Please note that the last day to claim credit is Tuesday, April 23rd.

A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation

If you would like to view this program in a group, please contact Jason Patterson at jpatterson@paradigmmc.com or by phone at 845-398-5944 for further instructions

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.

This activity is supported by educational grants from AbbVie, Inc.; Genentech, Inc.; Merck & Co., Inc.; Pharmacyclics, Inc.; and Takeda Oncology.

Disclosure:

As an organization accredited by the ACCME, City of Hope requires everyone who is in a position to control the content of an education activity to disclose prior to the activity all relevant financial relationships with any commercial interest. All disclosed relevant financial relationships will have been resolved prior to the commencement of the activity. We further require that prior to the activity faculty/presenters have disclosed their intention to discuss any off-label and/or investigational (not yet approved for any purpose) use of pharmaceuticals or medical devices.

Moderator/Presenter: Dr Amrita Krishnan has indicated that she is a Consultant for Celgene Corporation, Janssen Pharmaceuticals, Inc., Sutro Biopharma, Inc., Takeda Pharmaceutical Company Ltd. and zPREDICTA, Inc.; Receives Grant/Research Support from Janssen Pharmaceuticals, Inc.; On the Speakers Bureau for Celgene Corporation, Onyx Pharmaceuticals Inc. and Takeda Pharmaceutical Company Ltd.; is a Stock/Shareholder of Celgene Corporation.

Reviewer/Steering Committee: Dr Daneng Li has indicated that he does not have any relevant disclosures.

Paradigm Medical Communications, LLC, staff members have no financial relationships to disclose.

Registration:

To register for this complimentary meeting, please click Continue below or call toll-free: (877) 252-5100, ext. 1.